COVID-19 has ushered in a new wave of healthcare innovations from technological adoption to regulatory updates across the pharma and medical device industry in Asia.
In this summit, we bring you the latest insights and expert perspectives on how pharma and medical device can keep up with digital health; how they can create patient-centered digital health innovations; and how they can activate new business segments via digital health to drive business digital growth.
Patient-centric Digital Healthcare
HCP Engagement Innovation
Pricing and Market Access
The Future of Healthcare in Asia: Digital Healthcare Ecosystems
The post-Covid Leapfrog: How Pharma is Ready for Healthcare Digital Transformation in Southeast Asia
A Brave New World: Embracing Hybrid HCP Engagement in Singapore and Malaysia
Personalized HCP Engagement Brought by the On-going Pandemic in the Evolving Indonesian Healthcare Landscape
How to Transform Customer Engagement Strategies for an Omnichannel World in SEA
The Omni-channel Healthcare Model in SEA
How can Internet Platform Support Digital Patient Engagement
Patient Lifecycle Digital Management Solution
Social Media Intelligence for Pharma to Make Effective Commercial Decisions across the Drug Lifecycle
HCP MCM Optimization Solution
Panel Discussion: Omni-channel Marketing of Pharma and Medical Devices in Asia
Navigate Market Access by RWD in Asia
How to Increase Patient Access and Adherence to Your Brand
Data & Analytics Solutions for Market Access Strategy
Integrate Data & Optimize Insights to Improve Business Outcomes
Using Connected Intelligence to Improve Decision-Making
Digital Therapeutics in Chronic Disease Management
Fireside Chat: How can Pharma and Medical Devices Extend Digital Therapeutics Based on Product Lines?
Compliance Orchestration across the Device Lifecycle
Fireside Chat: How Pharma can Harness AI & Machine Learning to Analyze Vast Customer Data Sets while still Adhering to Data Privacy Laws?
Wonderful Reviews• Offline sharing + online live streaming
•Medical giants such as AstraZeneca、Sanofi、Pfizer、UCB、GE Healthcare and Philips Healthcare explain the most useful and practical knowledge
Who Should Attend?
• Title Distribution
Retail Manager、Director;Marketing Manager、Director、GM、VP;Digital Transformation Manager、Director;Omni-channel Manager、Director、VP;Multi-channel Marketing Manager…;Ecommerce Manager、Director;Commercial Manager、Director…;Go-to-market manager;Others
• Industry Distribution
Phama;Medical Device;Hospital;DigitalSolution;Internet platform;Insurance;Consulting
ABOUT ECV DIGITAL HEALTHCARE
So far, ECV Digital Healthcare has successfully held five China digital healthcare industry summits.
The summit aims to gain insight into the latest development of the international medical industry from the digital transformation! Focus on many hot topics such as digital medical strategic transformation, digital therapy, digital growth of pharmaceutical machinery enterprises under the background of VBP, digital chronic disease management, medical technology innovation, digital marketing and retail innovation of medical devices, and jointly discuss how to ride the wind and waves and win the future under the tide of digital medical treatment.
The previous industry summits gathered leaders of internet medical industry such as Baidu Health, WeDoctor, Tencent Health and JD Health, as well as many pharmaceutical giants such as AstraZeneca, Sanofi, Novartis pharmaceutical, MSD and BeiGene, as well as representatives of medical devices such as Siemens Healthineers, Bristol Myers Squibb, Medtronic and Stryker to present the most cutting-edge industry trends and interpret the most burning dry goods for the guests.
Phone: +86 -15950466513
Official website for more details：http://www.ecvinternational.com/AsiaHealthcare/